Treatment of hyperthyroidism with potassium iodide.
Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks. In the thyrotoxic patients, the maximum decrease in serum T3 and T4 levels was observed 2 and 3 weeks, respectively, but in some cases remained normal even at 5 weeks. The euthyroid persons showed a small decrease in T4 and T3 and an increase in serum TSH.
Philippou
G
G
Athens University, Department of Clinical Therapeutics, Alexandra General Hospital, Greece.
Piperingos
G
G
Souvatzoglou
A
A
Koutras
D A
DA
Moulopoulos
S D
SD
D000328:Adult; D005260:Female; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D008297:Male; D011193:Potassium Iodide / Q000627:therapeutic use*; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D014284:Triiodothyronine; D011193:Potassium Iodide; D013972:Thyrotropin; D013974:Thyroxine